ATE185484T1 - Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge - Google Patents

Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge

Info

Publication number: ATE185484T1
Authority: AT; Austria
Prior art keywords: treatment; adenosine; lungs; production; medicinal product
Prior art date: 1993-04-21

Application number

AT94903224T

Other languages

English (en)

Inventor

Alf Sollevi

Original Assignee

Item Dev Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-21

Filing date

1994-01-03

Publication date

1999-10-15

1994-01-03 Application filed by Item Dev Ab filed Critical Item Dev Ab

1999-10-15 Application granted granted Critical

1999-10-15 Publication of ATE185484T1 publication Critical patent/ATE185484T1/de

Links

OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title abstract 4
239000002126 C01EB10 - Adenosine Substances 0.000 title abstract 2
229960005305 adenosine Drugs 0.000 title abstract 2
238000006243 chemical reaction Methods 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
210000004072 lung Anatomy 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
238000000034 method Methods 0.000 abstract 2
208000031729 Bacteremia Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
230000004913 activation Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1
210000003462 vein Anatomy 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

AT94903224T 1993-04-21 1994-01-03 Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge ATE185484T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE19939301324A SE9301324D0 (sv)	1993-04-21	1993-04-21	New method of treatment

Publications (1)

Publication Number	Publication Date
ATE185484T1 true ATE185484T1 (de)	1999-10-15

Family

ID=20389651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94903224T ATE185484T1 (de)	1993-04-21	1994-01-03	Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge

Country Status (9)

Country	Link
US (1)	US5648341A (de)
EP (1)	EP0695185B1 (de)
JP (1)	JPH08508710A (de)
AT (1)	ATE185484T1 (de)
AU (1)	AU5724694A (de)
CA (1)	CA2160689C (de)
DE (1)	DE69421174T2 (de)
SE (1)	SE9301324D0 (de)
WO (1)	WO1994004017A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL121272A (en) *	1997-07-10	2000-06-01	Can Fite Technologies Ltd	Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
US5998386A (en) *	1997-09-19	1999-12-07	Feldman; Arthur M.	Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
CN101453984A (zh) *	2006-03-31	2009-06-10	艾登欧比公司	使用腺苷和肌苷组合用于诊断和治疗的组合物、方法和试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5231086A (en) *	1985-09-24	1993-07-27	Item Development Aktiebolag	Continuous administration adenosine to increase myocardial blood flow
US5104859A (en) *	1985-09-24	1992-04-14	Solimedco Aktiebolag	Continuous administration of adenosine to reduce pulmonary vascular resistance

1993
- 1993-04-21 SE SE19939301324A patent/SE9301324D0/xx unknown
- 1993-10-28 US US08/144,803 patent/US5648341A/en not_active Expired - Lifetime
1994
- 1994-01-03 WO PCT/SE1994/000001 patent/WO1994004017A2/en not_active Ceased
- 1994-01-03 AT AT94903224T patent/ATE185484T1/de not_active IP Right Cessation
- 1994-01-03 EP EP94903224A patent/EP0695185B1/de not_active Expired - Lifetime
- 1994-01-03 DE DE69421174T patent/DE69421174T2/de not_active Expired - Fee Related
- 1994-01-03 JP JP6506175A patent/JPH08508710A/ja active Pending
- 1994-01-03 CA CA002160689A patent/CA2160689C/en not_active Expired - Lifetime
- 1994-01-03 AU AU57246/94A patent/AU5724694A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU5724694A (en)	1994-03-15
DE69421174T2 (de)	2000-02-10
CA2160689C (en)	1999-11-02
WO1994004017A2 (en)	1994-03-03
EP0695185B1 (de)	1999-10-13
EP0695185A1 (de)	1996-02-07
WO1994004017A3 (en)	1994-09-01
SE9301324D0 (sv)	1993-04-21
US5648341A (en)	1997-07-15
JPH08508710A (ja)	1996-09-17
DE69421174D1 (de)	1999-11-18
CA2160689A1 (en)	1994-03-03

Similar Documents

Publication	Publication Date	Title
DE3687501D1 (de)	1993-02-25	Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
ATE324884T1 (de)	2006-06-15	Verwendung von gamma-linolensäure oder dihomogammalinolensäure zur herstellung eines medikaments zur behandlung von huntington's chorea
ATE254926T1 (de)	2003-12-15	Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten.
ATE231885T1 (de)	2003-02-15	Verwendung von komplement-inhibitoren zur herstellung eines arzneimittels zur prophylaxe und therapie von entzündlichen darm- und hauterkrankungen sowie purpura
DE69201948D1 (de)	1995-05-11	Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
CA2122612A1 (en)	1993-05-13	Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE218164T1 (de)	2002-06-15	Hemmung der fortpflanzung von arterienglattmuskelzellen
DE3855113D1 (de)	1996-04-25	Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
DE69113386D1 (de)	1995-11-02	Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE59005469D1 (de)	1994-05-26	Verfahren zur herstellung von dmt-zwischenprodukt bestimmter reinheit sowie dessen weiterverarbeitung zu reinst-dmt und/oder mittel- oder hochreiner terephthalsäure.
ATE157879T1 (de)	1997-09-15	Transformierte erythrozyten, verfahren zu deren herstellung, und ihre verwendung in pharmazeutischen zusammensetzungen
DE3873578D1 (de)	1992-09-17	Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
HUT40436A (en)	1986-12-28	Process for production pirrolo-benzimidasoles and medical preparatives containing thereof
HUT58037A (en)	1992-01-28	Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
ATE185484T1 (de)	1999-10-15	Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
ATE72120T1 (de)	1992-02-15	Verwendung von petasites-extrakten zur herstellung eines arzneimittels zur behandlung von gastrointestinalen erkrankungen.
GR930300100T1 (de)	1993-10-29
DE3766619D1 (de)	1991-01-17	Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.
FR2610633B1 (fr)	1992-09-18	Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament
SE7706425L (sv)	1977-12-04	Forfarande for framstellning av polyribonukleotider med aktivitet vid alstrandet av leukocyter och blodplettar
DE3787437D1 (de)	1993-10-21	Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems.
ATE146185T1 (de)	1996-12-15	11beta-substituierte 14,17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
EP0370378A3 (de)	1991-11-27	Pyrrolidin-2-carbonsäure-Derivate mit psychotroper Wirkung
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
EP0896059A3 (de)	1999-07-07	Verfahren zur Erzeugung von pathogen-resistenten Pflanzen

Legal Events

Date	Code	Title	Description
2000-02-15	UEP	Publication of translation of european patent specification
2007-10-15	REN	Ceased due to non-payment of the annual fee